Integrating meta-analysis of microarray data and targeted proteomics for biomarker identification: Application in breast cancer

Journal of Proteome Research

Volumn 13, Issue 6, 2014, Pages 2897-2909

  Pavlou, Maria P ^a,b   Dimitromanolakis, Apostolos ^b   Martinez Morillo, Eduardo ^c   Smid, Marcel ^d   Foekens, John A ^d   Diamandis, Eleftherios P ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

breast cancer prognosis; gene expression data meta analysis; mass spectrometry; selected reaction monitoring; targeted proteomics

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE 1; ESTROGEN RECEPTOR; KARYOPHERIN; KARYOPHERIN ALPHA2; PROTEOME; TISSUE EXTRACT; TRANSCRIPTOME; UNCLASSIFIED DRUG; CDK1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; KARYOPHERIN ALPHA; KPNA2 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEOMICS; QUANTITATIVE ANALYSIS; SELECTED REACTION MONITORING; AGED; AMINO ACID SEQUENCE; BREAST TUMOR; CHEMISTRY; DNA MICROARRAY; GENETICS; META ANALYSIS; META ANALYSIS (TOPIC); METABOLISM; MOLECULAR GENETICS; MORTALITY; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR RECURRENCE;

ADULT; AGED; ALPHA KARYOPHERINS; AMINO ACID SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; META-ANALYSIS AS TOPIC; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROTEOMICS; RECEPTORS, ESTROGEN; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84902089820     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500352e     Document Type: Article

References (51)

1. Rakha, E. A.; Reis-Filho, J. S.; Ellis, I. O. Combinatorial biomarker expression in breast cancer Breast Cancer Res. Treat. 2010, 120 (2) 293-308
2. Lange, V.; Picotti, P.; Domon, B.; Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial Mol. Syst. Biol. 2008, 4, 222
3. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics Ca-Cancer J. Clin 2011, 61 (2) 69-90
4. Reis-Filho, J. S.; Pusztai, L. Gene expression profiling in breast cancer: classification, prognostication, and prediction Lancet 2011, 378 (9805) 1812-1823
5. Edgar, R.; Domrachev, M.; Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository Nucleic Acids Res. 2002, 30 (1) 207-210
6. Parkinson, H.; Sarkans, U.; Kolesnikov, N. ArrayExpress update - an archive of microarray and high-throughput sequencing-based functional genomics experiments Nucleic Acids Res. 2011, 39 (Database issue) D1002-D1004
7. Pavlou, M. P.; Diamandis, E. P.; Blasutig, I. M. The long journey of cancer biomarkers from the bench to the clinic Clin. Chem. 2013, 59 (1) 147-157
8. Banks, R. E.; Dunn, M. J.; Hochstrasser, D. F. Proteomics: new perspectives, new biomedical opportunities Lancet 2000, 356 (9243) 1749-1756
9. Umar, A.; Kang, H.; Timmermans, A. M. Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer Mol. Cell. Proteomics 2009, 8 (6) 1278-1294
10. Liu, N. Q.; Braakman, R. B.; Stingl, C. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue J. Mammary Gland Biol. Neoplasia 2012, 17 (2) 155-164
11. Pavlou, M. P.; Dimitromanolakis, A.; Diamandis, E. P. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer Proteomics 2013, 13 (7) 1083-1095
12. Desmedt, C.; Piette, F.; Loi, S. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin. Cancer Res. 2007, 13 (11) 3207-3214
13. Wang, Y.; Klijn, J. G.; Zhang, Y. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer Lancet 2005, 365 (9460) 671-679
14. Sabatier, R.; Finetti, P.; Cervera, N. A gene expression signature identifies two prognostic subgroups of basal breast cancer Breast Cancer Res. Treat. 2011, 126 (2) 407-420
15. Ivshina, A. V.; George, J.; Senko, O. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res. 2006, 66 (21) 10292-10301
16. Luo, L. Y.; Diamandis, E. P.; Look, M. P.; Soosaipillai, A. P.; Foekens, J. A. Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance Br. J. Cancer 2002, 86 (11) 1790-1796
17. Drabovich, A. P.; Pavlou, M. P.; Dimitromanolakis, A.; Diamandis, E. P. Quantitative analysis of energy metabolic pathways in MCF-7 breast cancer cells by selected reaction monitoring assay Mol. Cell. Proteomics 2012, 11, 422-434
18. MacLean, B.; Tomazela, D. M.; Shulman, N. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-968
19. Liu, N. Q.; Dekker, L. J.; Stingl, C. Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches J. Proteome Res. 2013, 12 (10) 4627-4641
20. Jonsdottir, K.; Zhang, H.; Jhagroe, D. The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer Breast Cancer Res. Treat. 2012, 135 (2) 381-390
21. Germain, D. R.; Graham, K.; Glubrecht, D. D.; Hugh, J. C.; Mackey, J. R.; Godbout, R. DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer Breast Cancer Res. Treat. 2011, 127 (1) 53-63
22. Kuzyk, M. A.; Smith, D.; Yang, J. Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol. Cell. Proteomics 2009, 8 (8) 1860-1877
23. Krisp, C.; McKay, M. J.; Wolters, D. A.; Molloy, M. P. Multidimensional protein identification technology-selected reaction monitoring improving detection and quantification for protein biomarker studies Anal. Chem. 2012, 84 (3) 1592-1600
24. Rafalko, A.; Dai, S.; Hancock, W. S.; Karger, B. L.; Hincapie, M. Development of a Chip/Chip/SRM platform using digital chip isoelectric focusing and LC-Chip mass spectrometry for enrichment and quantitation of low abundance protein biomarkers in human plasma J. Proteome Res. 2012, 11 (2) 808-817
25. Shi, T.; Fillmore, T. L.; Sun, X. Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (38) 15395-15400
26. Whiteaker, J. R.; Zhao, L.; Zhang, H. Y. Antibody-based enrichment of peptides on magnetic beads for mass-spectrometry-based quantification of serum biomarkers Anal. Biochem. 2007, 362 (1) 44-54
27. Mortstedt, H.; Karedal, M. H.; Jonsson, B. A.; Lindh, C. H. Screening method using selected reaction monitoring for targeted proteomics studies of nasal lavage fluid J. Proteome Res. 2013, 12 (1) 234-247
28. Ma, S.; Kosorok, M. R. Detection of gene pathways with predictive power for breast cancer prognosis BMC Bioinf. 2010, 11, 1
29. Yau, C.; Esserman, L.; Moore, D. H.; Waldman, F.; Sninsky, J.; Benz, C. C. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer Breast Cancer Res. 2010, 12 (5) R85
30. Molloy, T. J.; Roepman, P.; Naume, B.; van't Veer, L. J. A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients PLoS One 2012, 7 (2) e32426
31. Rody, A.; Karn, T.; Liedtke, C. A clinically relevant gene signature in triple negative and basal-like breast cancer Breast Cancer Res. 2011, 13 (5) R97
32. Shen, R.; Ghosh, D.; Chinnaiyan, A. M. Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data BMC Genomics 2004, 5 (1) 94
33. Miecznikowski, J. C.; Wang, D.; Liu, S.; Sucheston, L.; Gold, D. Comparative survival analysis of breast cancer microarray studies identifies important prognostic genetic pathways BMC Cancer 2010, 10, 573
34. Wirapati, P.; Sotiriou, C.; Kunkel, S. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures Breast Cancer Res. 2008, 10 (4) R65
35. Li, J.; Lenferink, A. E.; Deng, Y. Identification of high-quality cancer prognostic markers and metastasis network modules Nat. Commun. 2010, 1, 34
36. Ransohoff, D. F. Rules of evidence for cancer molecular-marker discovery and validation Nat. Rev. Cancer 2004, 4 (4) 309-314
37. Paik, S.; Shak, S.; Tang, G. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N. Engl. J. Med. 2004, 351 (27) 2817-2826
38. Kirkbride, K. C.; Sung, B. H.; Sinha, S.; Weaver, A. M. Cortactin: a multifunctional regulator of cellular invasiveness Cell Adhes. Migr. 2011, 5 (2) 187-198
39. Hui, S.; Choi, J.; Zaidi, S. Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formation Circ. Res. 2011, 108 (9) 1053-1062
40. Lundgren, K.; Holm, K.; Nordenskjold, B.; Borg, A.; Landberg, G. Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer Breast Cancer Res. 2008, 10 (5) R81
41. Greenwood, C.; Metodieva, G.; Al-Janabi, K. Stat1 and CD74 overexpression is co-dependent and linked to increased invasion and lymph node metastasis in triple-negative breast cancer J. Proteomics 2012, 75 (10) 3031-3040
42. Leth-Larsen, R.; Lund, R.; Hansen, H. V. Metastasis-related plasma membrane proteins of human breast cancer cells identified by comparative quantitative mass spectrometry Mol. Cell. Proteomics 2009, 8 (6) 1436-1449
43. Medina-Ramirez, C. M.; Goswami, S.; Smirnova, T. Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance Cancer Res. 2011, 71 (24) 7705-7715
44. Singh, P.; Yang, M.; Dai, H. Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers Mol. Cancer Res. 2008, 6 (11) 1710-1717
45. Cadenas, C.; Franckenstein, D.; Schmidt, M. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Breast Cancer Res. 2010, 12 (3) R44
46. Hasegawa, T.; Asanuma, H.; Ogino, J. Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor Hum. Pathol. 2013, 44 (7) 1271-1277
47. Nuzzo, R. Scientific method: statistical errors Nature 2014, 506 (7487) 150-152
48. Johnson, V. E. Revised standards for statistical evidence Proc. Natl. Acad. Sci. U. S. A. 2013, 110 (48) 19313-19317
49. Dahl, E.; Kristiansen, G.; Gottlob, K. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer Clin. Cancer Res. 2006, 12 (13) 3950-3960
50. Dankof, A.; Fritzsche, F. R.; Dahl, E. KPNA2 protein expression in invasive breast carcinoma and matched peritumoral ductal carcinoma in situ Virchows Arch. 2007, 451 (5) 877-881
51. Gluz, O.; Wild, P.; Meiler, R. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity Int. J. Cancer 2008, 123 (6) 1433-1438